Vimarsana
Biggest News Aggregation in the World

Page 9 - Benchmark Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Benchmark Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Benchmark Research Today - Breaking & Trending Today

Sacramento researcher explains Johnson & Johnson vaccine - Vimarsana News

Sacramento researcher explains Johnson & Johnson vaccine

Dr. Rusty Oshita said it does a great job preventing poor outcomes of COVID-19. Author: Mike Duffy Updated: 9:14 AM PST January 30, 2021 SACRAMENTO, Calif. — A third COVID-19 vaccine, produced by Johnson & Johnson might soon be available for use in the United States. One of the companies helping to test the vaccine, Benchmark Research, has a branch in Sacramento. Dr. Rusty Oshita is Benchmark’s principal investigator in Sacramento. "In terms of the efficacy, what we know across the board, and that is all comers and across different continents that this stud...

Source: abc10.com
I volunteered to test the Moderna coronavirus vaccine. Here's what the side effects were like, and why I want my experience to give people hope. - Vimarsana News

I volunteered to test the Moderna coronavirus vaccine. Here's what the side effects were like, and why I want my experience to give people hope.

I volunteered to test the Moderna coronavirus vaccine. Here's what the side effects were like, and why I want my experience to give people hope. insider@insider.com (Elle Hardy) © Provided by Business Insider Elle Hardy. Elle Hardy Journalist Elle Hardy is taking part in a phase-three trial of Moderna's mRNA-1273 vaccine, which was just approved in the UK and has been shown to be 94.5% effective. The UK government has ordered 17 million doses of Moderna's shot, but it's unlikely to roll out before March. The shot was approved for use in the US in December. After a slight re...

Source: msn.com